Evidence map›Paper›PMID 36194154›Full record

ArticleMicrobiology spectrum2022

Noise in a Metabolic Pathway Leads to Persister Formation in Mycobacterium tuberculosis.

Jeffrey Quigley, Kim Lewis

Abstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Molecular Basis of Persister Awakening and Lag-Phase Recovery inInternational journal of molecular sciences · 2026
    Review
  7. Beyond culturability: VBNC-like and differentially culturableFrontiers in cellular and infection microbiology · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Antibiotics (Basel, Switzerland) · 2024
    Review
  15. Fate ofFrontiers in microbiology · 2024
    Article
  16. Dual Inhibition ofJournal of medicinal chemistry · 2023
    Article
  17. Eradication of Drug-TolerantMicroorganisms · 2023
    Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jeffrey QuigleyAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.
Kim LewisAntimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.ORCID 0000-0002-1621-7664

Funding

A general mechanism of persister formationR01AI141966 · NIAID · NORTHEASTERN UNIVERSITY · PI LEWIS, KIM, PAULSSON, JOHAN · 2019 to 2022
$2.9M
NIAID NIH HHS R01 AI141966
6 · The paper itself

Abstract

Tuberculosis is difficult to treat due to dormant cells formed in response to immune stress and stochastically formed persisters, both of which are tolerant of antibiotics. Bactericidal antibiotics kill by corrupting their energy-dependent targets. We reasoned that stochastic variation, or noise, in the expression of an energy-generating component will produce rare persister cells. In sorted M. tuberculosis cells grown on acetate, there is considerable cell-to-cell variation in the level of mRNA coding for AckA, the acetate kinase. Quenching the noise by overexpressing

Indexed as

Mycobacterium tuberculosisTuberculosis, Lymph NodeAcetate KinaseAnti-Bacterial AgentsHumansMetabolic Networks and PathwaysRNA, MessengerAcetate KinaseAnti-Bacterial AgentsRNA, Messengerantibiotic toleranceMycobacterium tuberculosispersisters

Identifiers

PMID36194154
PMCPMC9602276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.